Compositions and methods related to heart failure

Details for Australian Patent Application No. 2005274763 (hide)

Owner NitroMed, Inc.

Inventors Sabolinski, Michael L.; Worcel, Manuel

Agent Peter Maxwell & Associates

Pub. Number AU-A-2005274763

PCT Pub. Number WO2006/020244

Priority 60/610,901 20.09.04 US; 60/684,892 26.05.05 US; 60/622,781 29.10.04 US; 60/600,354 11.08.04 US; 60/588,390 16.07.04 US; 60/669,925 11.04.05 US; 60/689,520 13.06.05 US; 60/625,056 05.11.04 US

Filing date 18 July 2005

Wipo publication date 23 February 2006

International Classifications

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/15 (2006.01) - Oximes (CNO)

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/020244 Priority application(s): WO2006/020244

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274764-Bone distraction apparatus

2005274745-Impact assessment system and method for determining emergent criticality